Skip to main content
SpringerLink
Log in

Immunology of Uveitis

  • Chapter
Intraocular Inflammation

  • 443 Accesses

Abstract

Today we are able to differentiate approximately a hundred entities of intraocular inflammations and group them into anatomical types like anterior, intermediate, posterior, and panuveitis. This book will cover most of the reported entities. A few of these entities have highly typical clinical findings, so that the specialist easily may be able to determine the entity, leading to therapy. But a lot of entities develop similarities in their clinical appearance (similar endothelial precipitates, similar chorioretinal infiltrations, similar retinal necrosis) and also similar complications (elevated intraocular pressure, cataract formation, and macular edema).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Agarwal RK, Caspi RR (2004) Rodent models of experimental autoimmune uveitis. Methods Mol Med 102:395

    CAS  PubMed  Google Scholar 

  2. Agarwal RK, Kang Y, Zambidis E, Scott DW, Chan CC, Caspi RR (2000) Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest 106:245

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Allensworth JJ, Planck SR, Rosenbaum JT, Rosenzweig HL (2011) Investigation of the differential potentials of TLR agonists to elicit uveitis in mice. J Leukoc Biol 90:1159–1166

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395

    Article  CAS  PubMed  Google Scholar 

  5. Apte RS, Mayhew E, Niederkorn JY (1997) Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors. Invest Ophthalmol Vis Sci 38:1277–1282

    CAS  PubMed  Google Scholar 

  6. Apte RS, Niederkorn JY (1996) Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol 156:2667–2673

    CAS  PubMed  Google Scholar 

  7. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY (1998) Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160:5693–5696

    CAS  PubMed  Google Scholar 

  8. Avichezer D, Grajewski RS, Chan CC, Mattapallil MJ, Silver PB, Raber JA, Liou GI, Wiggert B, Lewis GM, Donoso LA, Caspi RR (2003) An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J Exp Med 198:1665

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Baarsma GS, Priem HA, Kijlstra A (1990) Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res 9(Suppl):63–68

    Article  PubMed  Google Scholar 

  10. Bagenstose LM, Agarwal RK, Silver PB, Harlan DM, Hoffmann SC, Kampen RL, Chan CC, Caspi RR (2005) Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance. J Immunol 175:124

    Article  CAS  PubMed  Google Scholar 

  11. Bejjani RA, Andrieu C, Bloquel C, Berdugo M, BenEzra D, Behar-Cohen F (2007) Electrically assisted ocular gene therapy. Surv Ophthalmol 52:196

    Article  PubMed  Google Scholar 

  12. Bettelli E, Oukka M, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8:345

    Article  CAS  PubMed  Google Scholar 

  13. Beutelspacher SC, Pillai R, Watson MP et al (2006) Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 36:690–700

    Article  CAS  PubMed  Google Scholar 

  14. Bhat A et al (2009) Colchicine revisited. Ann N Y Acad Sci 1173:766–773

    Article  CAS  PubMed  Google Scholar 

  15. Billingham RE, Krohn PL, Medawar PB (1951) Effect of cortisone on survival of skin homografts in rabbits. Br Med J 1:1157–1163

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Bonini S, Micera A, Iovieno A, Lambiase A, Bonini S (2005) Expression of toll-like receptors in healthy and allergic conjunctiva. Ophthalmology 112:1528–1534

    Article  PubMed  Google Scholar 

  17. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34:3579–3584

    CAS  PubMed  Google Scholar 

  18. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC (1973) Acute anterior uveitis and HL-A 27. Lancet 2:994–996

    Article  Google Scholar 

  19. Broekhuyse RM, Kuhlmann ED, Winkens HJ (1992) Experimental autoimmune anterior uveitis (EAAU). II. Dose-dependent induction and adoptive transfer using a melanin-bound antigen of the retinal pigment epithelium. Exp Eye Res 55:401

    Article  CAS  PubMed  Google Scholar 

  20. Broekhuyse RM, Kuhlmann ED, Winkens HJ (1992) Experimental autoimmune posterior uveitis accompanied by epitheloid cell accumulations (EAPU). A new type of experimental ocular disease induced by immunization with PEP-65, a pigment epithelial polypeptide preparation. Exp Eye Res 55:819

    Article  CAS  PubMed  Google Scholar 

  21. Broekhuyse RM, Kuhlmann ED, Winkens HJ (1996) Experimental melanin-protein induced uveitis (EMIU) is the sole type of uveitis evoked by a diversity of ocular melanin preparations and melanin-derived soluble polypeptides. Jpn J Ophthalmol 40:459

    CAS  PubMed  Google Scholar 

  22. Buenafe AC, Offner H, Machnicki M, Elerding H, Adlard K, Jacobs R, Vandenbark AA, Adamus G (1998) EAE TCR motifs and antigen recognition in myelin basic protein-induced anterior uveitis in Lewis rats. J Immunol 161:2052

    CAS  PubMed  Google Scholar 

  23. Camelo S, Kezic J, Shanley A, Rigby P, McMenamin PG (2006) Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes. Invest Ophthalmol Vis Sci 47:1039–1046

    Article  PubMed  Google Scholar 

  24. Caorsi R, Federici S, Gattorno M (2012) Biologic drugs in autoinflammatory syndromes. Autoimmun Rev 12(1):81–86

    Article  CAS  PubMed  Google Scholar 

  25. Caspi RR (2006) Animal models of autoimmune and immune-mediated uveitis (http://dx.doi.org/10.1016/j.ddmod.2006.03.005). Drug Discov Today Dis Mod (http://www.sciencedirect.com/science/journal/17406757) 3:3

    Google Scholar 

  26. Caspi RR (2006) Mechanisms underlying autoimmune uveitis (http://dx.doi.org/10.1016/j.ddmec.2006.05.006). Drug Discov Today Dis Mech (http://www.sciencedirect.com/dd4/journal/17406765) 3:199

    Google Scholar 

  27. Caspi RR (2006) Ocular autoimmunity: the price of privilege? Immunol Rev 213:23

    Article  PubMed  Google Scholar 

  28. Caspi RR, Chan CC, Grubbs BG, Silver PB, Wiggert B, Parsa CF, Bahmanyar S, Billiau A, Heremans H (1994) Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol 152:890

    CAS  PubMed  Google Scholar 

  29. Caspi RR, Roberge FG, Nussenblatt RB (1987) Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 237:1029–1032

    Article  CAS  PubMed  Google Scholar 

  30. Chang JH, McCluskey P, Wakefield D (2004) Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci 45:1871–1878

    Article  PubMed  Google Scholar 

  31. Chen J, Fujimoto C, Vistica BP, He J, Wawrousek EF, Kelsall B, Gery I (2006) Active participation of antigen-nonspecific lymphoid cells in immune-mediated inflammation. J Immunol 177:3362

    Article  CAS  PubMed  Google Scholar 

  32. Chen L, Yang P, Zhou H et al (2008) Diminished frequency and function of CD4 + CD25 high regulatory T cells associated with active uveitis in Vogt-Koyanagi- Harada syndrome. Invest Ophthalmol Vis Sci 49(8):3475–3482

    Article  PubMed  Google Scholar 

  33. Chevrel G et al (2001) Renal type AA amyloidosis associated with rheumatoid arthritis: a cohort study showing improved survival on treatment with pulse cyclophosphamide. Rheumatology (Oxford) 40(7):821–825

    Article  CAS  Google Scholar 

  34. Chong WP, Horai R, Mattapallil MJ, Silver PB, Chen J, Zhou R, Sergeev Y, Villasmil R, Chan CC, Caspi RR (2014) IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses. J Autoimmun 50:12–22

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Chui JJ, Li MW, Di Girolamo N, Chang JH, McCluskey PJ, Wakefield D (2010) Iris pigment epithelial cells express a functional lipopolysaccharide receptor complex. Invest Ophthalmol Vis Sci 51:2558–2567

    Article  PubMed  Google Scholar 

  36. Crane IJ, Xu H, Wallace C, Manivannan A, Mack M, Liversidge J, Marquez G, Sharp PF, Forrester JV (2006) Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J Leukoc Biol 79:435

    Article  CAS  PubMed  Google Scholar 

  37. D’Orazio TJ, DeMarco BM, Mayhew ES, Niederkorn JY (1999) Effect of aqueous humor on apoptosis of inflammatory cell types. Invest Ophthalmol Vis Sci 40:1418–1426

    PubMed  Google Scholar 

  38. de Smet MD, Yamamoto JH, Mochizuki M, Gery I, Singh VK, Shinohara T, Wiggert B, Chader GJ, Nussenblatt RB (1990) Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 110:135–142

    Article  PubMed  Google Scholar 

  39. Descamps FJ, Kangave D, Cauwe B, Martens E, Geboes K, Abu El-Asrar A, Opdenakker G (2008) Interphotoreceptor retinoid-binding protein as biomarker in systemic autoimmunity with eye inflictions. J Cell Mol Med 12:2449–2456

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. DeVoss J, Hou Y, Johannes K, Lu W, Liou GI, Rinn J, Chang H, Caspi RR, Fong L, Anderson MS (2006) Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J Exp Med 203:2727

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Diedrichs-Mohring M, Nelson PJ, Proudfoot AE, Thurau SR, Wildner G (2005) The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance. J Neuroimmunol 164:22

    Article  PubMed  CAS  Google Scholar 

  42. Doria A et al (2012) Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12(1):22–30

    Article  CAS  PubMed  Google Scholar 

  43. Dullforce PA, Garman KL, Seitz GW et al (2004) APCs in the anterior uveal tract do not migrate to draining lymph nodes. J Immunol 172:6701–6708

    Article  CAS  PubMed  Google Scholar 

  44. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG (1996) Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 157:2262–2271

    CAS  PubMed  Google Scholar 

  45. Egwuagu CE, Charukamnoetkanok P, Gery I (1997) Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 159:3109

    CAS  PubMed  Google Scholar 

  46. Fang J, Fang D, Silver PB, Wen F, Li B, Ren X, Lin Q, Caspi RR, Su SB (2010) The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest Ophthalmol Vis Sci 51:3092–3099

    Article  PubMed Central  PubMed  Google Scholar 

  47. Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN (2005) Anti-TNF therapy: where have we got to in 2005? J Autoimmun 25(Suppl):26

    Article  CAS  PubMed  Google Scholar 

  48. Gallegos AM, Bevan MJ (2006) Central tolerance: good but imperfect. Immunol Rev 209:290

    Article  PubMed  Google Scholar 

  49. Gery I, Nussenblatt RB, Chan CC, Caspi RR (2002) Autoimmune diseases of the eye. In: Theophilopoulos AN, Bona CA (eds) The molecular pathology of autoimmune diseases. Taylor and Francis, New York, p 978

    Google Scholar 

  50. Grajewski RS, Silver PB, Agarwal RK, Su S-B, Chan C-C, Liou GI, Caspi RR (2006) Endogenous IRBP can be dispensable for generation of natural CD4 + CD25+ Tregs that protect from IRBP-induced retinal autoimmunity. J Exp Med 203:851

    Google Scholar 

  51. Gregerson DS (2002) Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity. Int Rev Immunol 21:101

    Article  CAS  PubMed  Google Scholar 

  52. Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ (1999) Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J Immunol 163:1073

    CAS  PubMed  Google Scholar 

  53. Gregory MS, Repp AC, Holhbaum AM, Saff RR, Marshak-Rothstein A, Ksander BR (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol 169:2727–2735

    Article  CAS  PubMed  Google Scholar 

  54. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189–1192

    Article  CAS  PubMed  Google Scholar 

  55. Halle A et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857–865

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Ham DI, Gentleman S, Chan CC, McDowell JH, Redmond TM, Gery I (2002) RPE65 is highly uveitogenic in rats. Invest Ophthalmol Vis Sci 43:2258

    PubMed  Google Scholar 

  57. Ham DI, Kim SJ, Chen J, Vistica BP, Fariss RN, Lee RS, Wawrousek EF, Takase H, Yu CR, Egwuagu CE, Chan CC, Gery I (2004) Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter. Invest Ophthalmol Vis Sci 45:857

    Article  PubMed  Google Scholar 

  58. Hara Y, Caspi RR, Wiggert B, Chan CC, Wilbanks GA, Streilein JW (1992) Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol 148:1685–1692

    CAS  PubMed  Google Scholar 

  59. Heuss ND, Lehmann U, Norbury CC, McPherson SW, Gregerson DS (2012) Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina. J Immunol 188:1191–1200

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Horai R, Silver PB, Chen J, Agarwal RK, Chong WP, Jittayasothorn Y, Mattapallil MJ, Nguyen S, Natarajan K, Villasmil R, Wang P, Karabekian Z, Lytton SD, Chan CC, Caspi RR (2013) Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen. J Autoimmun 44:21

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Hori J, Wang M, Miyashita M et al (2006) B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 177:5928–5935

    Article  CAS  PubMed  Google Scholar 

  62. Iaccarino L et al (2007) Mycophenolate mofetil in lupus glomerulonephritis: effectiveness and tolerability. Ann N Y Acad Sci 1110:516–524

    Article  CAS  PubMed  Google Scholar 

  63. Ichikawa T, Taguchi O, Takahashi T, Ikeda H, Takeuchi M, Tanaka T, Usui M, Nishizuka Y (1991) Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus. Clin Exp Immunol 86:112

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Ishitani A, Geraghty DE (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 89:3947–3951

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  65. Jha P, Bora PS, Bora NS (2007) The role of complement system in ocular diseases including uveitis and macular degeneration. Mol Immunol 44:3901–3908

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Jha P, Sohn JH, Xu Q et al (2006) The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 47:1030–1038

    Article  PubMed Central  PubMed  Google Scholar 

  67. Jha P, Sohn JH, Xu Q et al (2006) Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU). J Immunol 176:7221–7231

    Article  CAS  PubMed  Google Scholar 

  68. Jiang HR, Muckersie E, Robertson M, Forrester JV (2003) Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Invest Ophthalmol Vis Sci 44:1598

    Article  PubMed  Google Scholar 

  69. Kaestel CG, Jørgensen A, Nielsen M, Eriksen KW, Ødum N, Holst Nissen M, Röpke C (2002) Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res 74:627–637

    Article  CAS  PubMed  Google Scholar 

  70. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140(6):784–790

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Kezic J, Taylor S, Gupta S, Planck SR, Rosenzweig HL, Rosenbaum JT (2011) Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF. J Leukoc Biol 90:305–311

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Kilmartin DJ, Wilson D, Liversidge J, Dick AD, Bruce J, Acheson RW, Urbaniak SJ, Forrester JV (2001) Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol 85:281–286

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. Kim MK, Caspi RR, Nussenblatt RB, Kuwabara T, Palestine AG (1988) Intraocular trafficking of lymphocytes in locally induced experimental autoimmune uveoretinitis (EAU). Cell Immunol 112:430

    Article  CAS  PubMed  Google Scholar 

  74. Kitaichi N, Namba K, Taylor AW (2005) Inducible immune regulation following autoimmune disease in the immune-privileged eye. J Leukoc Biol 77:496–502

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197

    Article  CAS  PubMed  Google Scholar 

  76. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220–223

    Article  CAS  PubMed  Google Scholar 

  77. Kumar MV, Nagineni CN, Chin MS et al (2004) Innate immunity in the retina: Toll like receptor(TLR) signalling in human retinal pigment epithelial cells. J Neuroimmunol 153:7–15

    Article  CAS  PubMed  Google Scholar 

  78. Kumar A, Yu F-SX (2006) Toll-like receptors and corneal innate immunity. Curr Mol Med 6:327–337

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  79. Lambe T, Leung JC, Ferry H, Bouriez-Jones T, Makinen K, Crockford TL, Jiang HR, Nickerson JM, Peltonen L, Forrester JV, Cornall RJ (2007) Limited peripheral T cell anergy predisposes to retinal autoimmunity. J Immunol 178:4276

    Article  CAS  PubMed  Google Scholar 

  80. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96

    Article  CAS  PubMed  Google Scholar 

  81. Lass JH, Walter EI, Burris TE et al (1990) Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 31:1136–1148

    CAS  PubMed  Google Scholar 

  82. Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED (2003) Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64:1039–1044

    Article  PubMed  CAS  Google Scholar 

  83. Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA (2002) TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 169:4739–4744

    Article  PubMed  Google Scholar 

  84. Lee S, Koh YJ, Kim DH, Bang D, Nam IW, Lee KH, Park K (1988) A study of HLA antigens in Behcet’s Syndrome. Yonsei Med J 29:259–262

    Article  CAS  PubMed  Google Scholar 

  85. Lee N, Llano M, Carretero M et al (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 95:5199–5204

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  86. Levinson RD, Park MS, Rikkers SM, Reed EF, Smith JR, Martin TM, Rosenbaum JT, Foster CS, Sherman MD, Holland GN (2003) Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci 44:653–657

    Article  PubMed  Google Scholar 

  87. Li Z, Lim WK, Mahesh SP, Liu B, Nussenblatt RB (2005) Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J Immunol 174:5187

    Article  CAS  PubMed  Google Scholar 

  88. Liu X, Wang C, Ye Z, Kijlstra A, Yang P (2013) Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet’s disease. Invest Ophthalmol Vis Sci 54(9):6012–6017

    Article  CAS  PubMed  Google Scholar 

  89. Ljunggren HG, Karre K (1990) In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 11:237–244

    Article  CAS  PubMed  Google Scholar 

  90. Ljunggren HG, Ohlen C, Hoglund P, Franksson L, Karre K (1991) The RMA-S lymphoma mutant; consequences of a peptide loading defect on immunological recognition and graft rejection. Int J Cancer Suppl 6:38–44

    Article  CAS  PubMed  Google Scholar 

  91. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan C-C, Caspi RR (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799–810

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  92. Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100(6):818–824; discussion 825

    Article  CAS  PubMed  Google Scholar 

  93. Masters SL et al (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621–668

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  94. Masters SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11(10):897–904

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  95. Mattapallil MJ, Silver PB, Mattapallil JJ, Horai R, Karabekian Z, McDowell JH, Chan CC, James EA, Kwok WW, Sen HN, Nussenblatt RB, David CS, Caspi RR (2011) Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J Immunol 187:1977–1985

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. McDermott MF et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97(1):133–144

    Article  CAS  PubMed  Google Scholar 

  97. McPherson SW, Roberts JP, Gregerson DS (1999) Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis. J Immunol 163:4269

    CAS  PubMed  Google Scholar 

  98. Medzhitov R, Janeway CA Jr (1999) Innate immune induction of the adaptive immune response. Cold Spring Harb Symp Quant Biol 64:429

    Article  CAS  PubMed  Google Scholar 

  99. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762

    Article  CAS  PubMed  Google Scholar 

  100. Mellor AL, Munn D (2004) Policing pregnancy: Tregs help keep the peace. Trends Immunol 25:563–565

    Article  CAS  PubMed  Google Scholar 

  101. Mo JS, Streilein JW (2001) Immune privilege persists in eyes with extreme inflammation induced by intravitreal LPS. Eur J Immunol 31:3806–3815

    Article  CAS  PubMed  Google Scholar 

  102. Moll M, Kuemmerle-Deschner JB (2013) Inflammasome and cytokine blocking strategies in autoinflammatory disorders. Clin Immunol 147(3):242–275

    Article  CAS  PubMed  Google Scholar 

  103. Munn DH, Zhou M, Attwood JT et al (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191–1193

    Article  CAS  PubMed  Google Scholar 

  104. Namba K, Kitaichi N, Nishida T, Taylor AW (2002) Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol 72:946–952

    CAS  PubMed  Google Scholar 

  105. Niederkorn JY (1999) The immune privilege of corneal allografts. Transplantation 67:1503–1508

    Article  CAS  PubMed  Google Scholar 

  106. Niederkorn JY (2002) Immune privilege in the anterior chamber of the eye. Crit Rev Immunol 22:13–46

    Article  CAS  PubMed  Google Scholar 

  107. Niederkorn JY (2002) Immunology and immunomodulation of corneal transplantation. Int Rev Immunol 21:173–196

    Article  PubMed  Google Scholar 

  108. Niederkorn JY (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7:354–359

    Article  CAS  PubMed  Google Scholar 

  109. Niederkorn JY (2006) Anterior chamber-associated immune deviation and its impact on corneal allografts. Curr Opin Organ Transplant 11:360–365

    Article  Google Scholar 

  110. Niederkorn JY (2007) The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy 92:27–35

    Article  CAS  PubMed  Google Scholar 

  111. Niederkorn JY, Chiang EY, Ungchusri T, Stroynowski I (1999) Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 68:1790–1799

    Article  CAS  PubMed  Google Scholar 

  112. Nussenblatt R (2004) Orally and nasally induced tolerance studies in ocular inflammatory disease: guidance for future interventions. Ann N Y Acad Sci 1029:278

    Article  CAS  PubMed  Google Scholar 

  113. Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM (1999) Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci U S A 96:7462

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  114. Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, Buggage RR (2005) Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology 112:764

    Article  PubMed  Google Scholar 

  115. Park H et al (2012) Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol 12(8):570–580

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  116. Pennesi G, Mattapallil MJ, Sun SH, Avichezer D, Silver PB, Karabekian Z, David CS, Hargrave PA, McDowell JH, Smith WC, Wiggert B, Donoso LA, Chan CC, Caspi RR (2003) A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest 111:1171

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  117. Petrilli V et al (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19(6):615–622

    Article  CAS  PubMed  Google Scholar 

  118. Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS (1998) T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 39:754

    CAS  PubMed  Google Scholar 

  119. Redfern RL, McDermott AM (2010) Toll-like receptors in ocular surface disease. Exp Eye Res 90:679–687

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  120. Rizzo LV, Xu H, Chan CC, Wiggert B, Caspi RR (1998) IL-10 has a protective role in experimental autoimmune uveoretinitis. Int Immunol 10:807

    Article  CAS  PubMed  Google Scholar 

  121. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 94:11520–11525

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  122. Rouas-Freiss N, Khalil-Daher I, Marchal-Bras Goncalves R, Menier C, Dausset J, Carosella ED (1999) Role of HLA-G in maternal-fetal immune tolerance. Transplant Proc 31:724–725

    Article  CAS  PubMed  Google Scholar 

  123. Ryu YH, Kim JC (2007) Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor. Invest Ophthalmol Vis Sci 48:4148–4152

    Article  PubMed  Google Scholar 

  124. Schwartz RH (1990) A cell culture model for T lymphocyte clonal anergy. Science 248:1349

    Article  CAS  PubMed  Google Scholar 

  125. Shao H, Fu Y, Liao T, Peng Y, Chen L, Kaplan HJ, Sun D (2005) Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells. Invest Ophthalmol Vis Sci 46:596

    Article  PubMed  Google Scholar 

  126. Shao H, Woon MD, Nakamura S, Sohn JH, Morton PA, Bora NS, Kaplan HJ (2001) Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 42:2016

    CAS  PubMed  Google Scholar 

  127. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR (2007) The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J Immunol 179:3672–3679

    Article  CAS  PubMed  Google Scholar 

  128. Shindo Y, Inoko H, Yamamoto T, Ohno S (1994) HLA-DRB1 typing of Vogt-Koyanagi-Harada’s disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 78:223–226

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  129. Shinohara T, Singh VK, Tsuda M, Yamaki K, Abe T, Suzuki S (1990) S-antigen: from gene to autoimmune uveitis. Exp Eye Res 50:751

    Article  CAS  PubMed  Google Scholar 

  130. Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’ – autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36(1):4–8

    Article  CAS  PubMed  Google Scholar 

  131. Shugaiv E et al (2011) Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet’s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol 29(4 Suppl 67):S64–S67

    PubMed  Google Scholar 

  132. Silver PB, Agarwal RK, Su SB, Suffia I, Grajewski RS, Luger D, Chan CC, Mahdi RM, Nickerson JM, Caspi RR (2007) Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol 179:5146

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  133. Silver PB, Hathcock KS, Chan CC, Wiggert B, Caspi RR (2000) Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance. J Immunol 165:5041

    Article  CAS  PubMed  Google Scholar 

  134. Smith JR, Hart PH, Williams KA (1998) Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol 76:497

    Article  CAS  PubMed  Google Scholar 

  135. Smith JR, Verwaerde C, Rolling F, Naud MC, Delanoye A, Thillaye-Goldenberg B, Apparailly F, De Kozak Y (2005) Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. Hum Gene Ther 16:1037

    Article  CAS  PubMed  Google Scholar 

  136. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS (2000) Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 41:3492–3502

    PubMed Central  CAS  PubMed  Google Scholar 

  137. Song PI, Abraham TA, Park Y, Zivony AS, Harten B, Edelhauser HF, Ward SL, Armstrong CA, Ansel JC (2001) The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci 42:2867–2877

    CAS  PubMed  Google Scholar 

  138. Sonoda KH, Sakamoto T, Qiao H et al (2005) The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation. Immunology 116:390–399

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  139. Streilein JW (1987) Immune regulation and the eye: a dangerous compromise. FASEB J 1:199–208

    CAS  PubMed  Google Scholar 

  140. Streilein JW (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879–889

    Article  CAS  PubMed  Google Scholar 

  141. Streilein JW, Masli S, Takeuchi M, Kezuka T (2002) The eye’s view of antigen presentation. Hum Immunol 63:435–443

    Article  CAS  PubMed  Google Scholar 

  142. Streilein JW, Niederkorn JY (1981) Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 153:1058–1067

    Article  CAS  PubMed  Google Scholar 

  143. Stuart PM, Yin X, Plambeck S, Pan F, Ferguson TA (2005) The role of Fas ligand as an effector molecule in corneal graft rejection. Eur J Immunol 35:2591–2597

    Article  CAS  PubMed  Google Scholar 

  144. Sugita S, Horie S, Nakamura O, Futagami Y, Takase H, Keino H, Aburatani H, Katunuma N, Ishidoh K, Yamamoto Y, Mochizuki M (2008) Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol 181:7525–7536

    Article  CAS  PubMed  Google Scholar 

  145. Sugita S, Ng TF, Lucas PJ, Gress RE, Streilein JW (2006) B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J Immunol 176:118–127

    Article  CAS  PubMed  Google Scholar 

  146. Szpak Y, Vieville JC, Tabary T, Naud MC, Chopin M, Edelson C, Cohen JH, Dausset J, de Kozak Y, Pla M (2001) Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A 98:2572

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  147. Takase H, Yu CR, Mahdi RM, Douek DC, Dirusso GB, Midgley FM, Dogra R, Allende G, Rosenkranz E, Pugliese A, Egwuagu CE, Gery I (2005) Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals. Int Immunol 17:1131

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  148. Takeuchi M, Usui Y, Okunuki Y, Zhang L, Ma J, Yamakawa N, Hattori T, Kezuka T, Sakai J, Goto H (2010) Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet’s patients with uveitis. Invest Ophthalmol Vis Sci 51:3067–3075

    Article  PubMed  Google Scholar 

  149. Tang J, Zhu W, Silver PB, Su SB, Chan CC, Caspi RR (2007) Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol 178:5578

    Article  CAS  PubMed  Google Scholar 

  150. Tarrant TK, Silver PB, Chan CC, Wiggert B, Caspi RR (1998) Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J Immunol 161:122

    CAS  PubMed  Google Scholar 

  151. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B, Caspi RR (1999) Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 189:219

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  152. Taylor AW (1999) Ocular immunosuppressive microenvironment. Chem Immunol 73:72–89

    Article  CAS  PubMed  Google Scholar 

  153. Taylor AW (2003) Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol Biol (Noisy-le-Grand) 49:143

    CAS  Google Scholar 

  154. Taylor AW, Streilein JW, Cousins SW (1994) Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1:188–194

    Article  CAS  PubMed  Google Scholar 

  155. Taylor AW, Yee DG (2003) Somatostatin is an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 44:2644–2649

    Article  PubMed  Google Scholar 

  156. Taylor AW, Yee DG, Streilein JW (1998) Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest Ophthalmol Vis Sci 39:1372–1378

    CAS  PubMed  Google Scholar 

  157. Terrada C, Fisson S, De Kozak Y, Kaddouri M, Lehoang P, Klatzmann D, Salomon BL, Bodaghi B (2006) Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen. J Immunol 176:7171

    Article  CAS  PubMed  Google Scholar 

  158. Thurau SR, Mempel TR, Flugel A, Diedrichs-Mohring M, Krombach F, Kawakami N, Wildner G (2004) The fate of autoreactive, GFP+ T cells in rat models of uveitis analyzed by intravital fluorescence microscopy and FACS. Int Immunol 16:1573

    Article  CAS  PubMed  Google Scholar 

  159. Touitou I, Kone-Paut I (2008) Autoinflammatory disease. Best Pract Res Clin Rheumatol 22(5):811–829

    Article  CAS  PubMed  Google Scholar 

  160. van Dooremaal JC (1873) Die Entwicklung der in fremden Grund versetzten lebenden Gewebe. Albrecht Von Graefes Arch Ophthalmol 19:358–373.175

    Google Scholar 

  161. Wahlsten JL, Gitchell HL, Chan CC, Wiggert B, Caspi RR (2000) Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis. J Immunol 165:5480–5486

    Article  CAS  PubMed  Google Scholar 

  162. Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P (2010) The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol 94:271–274

    Article  PubMed  Google Scholar 

  163. Wallace GR, John Curnow S, Wloka K, Salmon M, Murray PI (2004) The role of chemokines and their receptors in ocular disease. Prog Retin Eye Res 23:435

    Article  CAS  PubMed  Google Scholar 

  164. Wang S, Boonman ZF, Li HC et al (2003) Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J Immunol 171:2789–2796

    Article  CAS  PubMed  Google Scholar 

  165. Wang RX, Yu CR, Mahdi RM, Egwuagu CE (2012) Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J Biol Chem 287:36012

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  166. Whitcup SM, DeBarge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC (1993) Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol 67:143

    Article  CAS  PubMed  Google Scholar 

  167. Wilbanks GA, Mammolenti M, Streilein JW (1991) Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 146:3018–3024

    CAS  PubMed  Google Scholar 

  168. Wilbanks GA, Streilein JW (1991) Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID- inducing, cell-associated signal exists in the peripheral blood. J Immunol 146:2610–2617

    CAS  PubMed  Google Scholar 

  169. Wildner G, Diedrichs-Mohring M (2004) Autoimmune uveitis and antigenic mimicry of environmental antigens. Autoimmun Rev 3:383

    Article  CAS  PubMed  Google Scholar 

  170. Willermain F et al (2012) Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Prog Retin Eye Res 31(2):182–194

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  171. Xu H, Silver PB, Tarrant TK, Chan CC, Caspi RR (2003) Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells. Invest Ophthalmol Vis Sci 44:4805

    Article  PubMed  Google Scholar 

  172. Yamagami S, Kawashima H, Tsuru T et al (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107–1111

    Article  CAS  PubMed  Google Scholar 

  173. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 71:361

    Article  CAS  PubMed  Google Scholar 

  174. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behçet’s disease. Br J Ophthalmol 77:584–589

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  175. Zen M et al (2011) The kaleidoscope of glucocorticoid effects on immune system. Autoimmun Rev 10(6):305–310

    Article  CAS  PubMed  Google Scholar 

  176. Zhou R, Horai R, Mattapallil MJ, Caspi RR (2011) A new look at immune privilege of the eye: dual role for the vision-related molecule retinoic acid. J Immunol 187:4170–4177

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  177. Zhou R, Horai R, Silver PB, Mattapallil MJ, Zárate-Bladés CR, Chong WP, Chen J, Rigden RC, Villasmil R, Caspi RR (2012) The living eye “disarms” uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition. J Immunol 188:1742–1750

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunology, National Eye Institute, NIH Building 10, Room 1ON222, Bethesda, MD, 20892, USA

    Rachel R. Caspi

  2. Laboratory of Immunology, University of Bristol, Bristol Eye Hospital, Lower Maudlin Street, Bristol, BS1 2LX, UK

    Andrew Dick

  3. Division of Applied Medicine, Section of Immunology and Infection, Institute of Medical Sciences, University of Aberdeen, Room 4.24, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK

    John Forrester

  4. Department of Internal Medicine II, University of Tuebingen, Otfried-Müller-Str. 10, Tübingen, 72076, Germany

    Reinhild Klein

  5. Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX, 75390-9057, USA

    Jerry Y. Niederkorn

  6. Department of Anatomy II, Friedrich Alexander University Erlangen-Nürnberg, Universitätsstr. 19, Erlangen, 91054, Germany

    Friedrich Paulsen

  7. Laboratory of Immunology, OHSU/Casey Eye Institute, 3375 SW Terwilliger Blvd., Portland, OR, 97239-4197, USA

    James Rosenbaum

  8. Laboratory of Immunology, The University of South Wales, Newport, UK

    Denis Wakefield

  9. Prince of Wales Hospital, High Street, Randwick, 2031, Australia

    Denis Wakefield

  10. Laboratory of Immunology, Centre of Ophthalmology, University of Tuebingen, Schleichstr. 12, Tuebingen, 72076, Germany

    Manfred Zierhut

Authors
  1. Rachel R. Caspi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Dick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Forrester
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reinhild Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jerry Y. Niederkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Friedrich Paulsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James Rosenbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Denis Wakefield
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Manfred Zierhut
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manfred Zierhut .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Caspi, R.R. et al. (2016). Immunology of Uveitis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation